Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hirsch

Showing results (971-980 of 1,259) with videos related to

Pageof 126
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2009
EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohortMarileila Varella-Garcia, Tetsuya Mitsudomi, Yashushi Yatabe, et al.
Cancer Investigation|April 4, 2017
Design and Rationale of the Metastatic Renal Cell Carcinoma (MaRCC) Registry: A Prospective Academic and Community-Based Study of Patients With Metastatic Renal Cell CancerNrupen A Bhavsar, Michael R Harrison, Bradford R Hirsch, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studiesLisa Licitra, Stephan Störkel, Keith M Kerr, et al.
Respiratory Research|November 9, 2019
Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancerMengting Zhou, Jun Fan, Zhenyu Li, et al.
Clinical Lung Cancer|July 28, 2016
Efficacy and Safety Results From a Phase II, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy for Advanced Squamous Cell Non-Small-Cell Lung CancerFred R Hirsch, Ramaswamy Govindan, Zanete Zvirbule, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2021
CCL19 associates with lymph node metastasis and inferior prognosis in patients with small cell lung cancerQian Liu, Meng Qiao, Zoltan Lohinai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
Contributions of KRAS and RAL in non-small-cell lung cancer growth and progressionSunny Guin, Yuanbin Ru, Murry W Wynes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 19, 2017
Comprehensive Analysis of EGFR-Mutant Abundance and Its Effect on Efficacy of EGFR TKIs in Advanced NSCLC with EGFR MutationsXuefei Li, Weijing Cai, Guohua Yang, et al.
Nutrients|February 7, 2020
Supplements and Nutritional Interventions to Augment High-Intensity Interval Training Physiological and Performance Adaptations-A Narrative ReviewScott C Forbes, Darren G Candow, Abbie E Smith-Ryan, et al.
Microbial Ecology|November 15, 2014
Soil pH determines microbial diversity and composition in the park grass experimentKateryna Zhalnina, Raquel Dias, Patricia Dörr de Quadros, et al.
Pageof 126

Showing results (971-980 of 1,259) with videos related to

Sort By:
Pageof 126
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2009
EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohortMarileila Varella-Garcia, Tetsuya Mitsudomi, Yashushi Yatabe, et al.
Cancer Investigation|April 4, 2017
Design and Rationale of the Metastatic Renal Cell Carcinoma (MaRCC) Registry: A Prospective Academic and Community-Based Study of Patients With Metastatic Renal Cell CancerNrupen A Bhavsar, Michael R Harrison, Bradford R Hirsch, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studiesLisa Licitra, Stephan Störkel, Keith M Kerr, et al.
Respiratory Research|November 9, 2019
Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancerMengting Zhou, Jun Fan, Zhenyu Li, et al.
Clinical Lung Cancer|July 28, 2016
Efficacy and Safety Results From a Phase II, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy for Advanced Squamous Cell Non-Small-Cell Lung CancerFred R Hirsch, Ramaswamy Govindan, Zanete Zvirbule, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2021
CCL19 associates with lymph node metastasis and inferior prognosis in patients with small cell lung cancerQian Liu, Meng Qiao, Zoltan Lohinai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
Contributions of KRAS and RAL in non-small-cell lung cancer growth and progressionSunny Guin, Yuanbin Ru, Murry W Wynes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 19, 2017
Comprehensive Analysis of EGFR-Mutant Abundance and Its Effect on Efficacy of EGFR TKIs in Advanced NSCLC with EGFR MutationsXuefei Li, Weijing Cai, Guohua Yang, et al.
Nutrients|February 7, 2020
Supplements and Nutritional Interventions to Augment High-Intensity Interval Training Physiological and Performance Adaptations-A Narrative ReviewScott C Forbes, Darren G Candow, Abbie E Smith-Ryan, et al.
Microbial Ecology|November 15, 2014
Soil pH determines microbial diversity and composition in the park grass experimentKateryna Zhalnina, Raquel Dias, Patricia Dörr de Quadros, et al.
Pageof 126